Topic:

March 2023

Investments to Support Access to Drugs for Rare Diseases

On March 22, 2023 the Government announced a total investment of up to $1.5 billion over three years in support of the first-ever National Strategy for Drugs for Rare Diseases to help increase access to, and affordability of, promising and effective drugs for rare diseases to improve the health of patients across Canada. For more information, please visit https://www.canada.ca/en/health-canada/news/2023/03/investments-to-support-access-to-drugs-for-rare-diseases.html

Lupus Blog Articles:

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Read

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Read

Megakaryocyte: a new player in systemic lupus erythematosus

Read